Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Corless

Showing results (21-30 of 208) with videos related to

Pageof 21
Sort By:
American Journal of Surgery|May 15, 2010
Sentinel lymph node staging of cutaneous melanoma: predictors and outcomesMichelle C Ellis, Roshanthi Weerasinghe, Christopher L Corless, et al.
Cancer Medicine|August 29, 2014
Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathwaysMaria A Pantaleo, Margherita Nannini, Christopher L Corless, et al.
The American Journal of Dermatopathology|February 10, 2012
BRAF and KRAS mutations in sporadic glomus tumorsAndrea Chakrapani, Andrea Warrick, Dylan Nelson, et al.
Gastrointestinal Endoscopy|August 28, 2002
Embryonal rhabdomyosarcoma in a 3-year-old child diagnosed at ERCP: case report and reviewGordon C Hunt, Christopher L Corless, Annie B Terry, et al.
American Journal of Surgery|May 30, 2002
Immunosuppression impact on long-term cardiovascular complications after liver transplantationJohn M Rabkin, Christopher L Corless, Hugo R Rosen, et al.
The American Journal of Pathology|May 10, 2002
KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in sizeChristopher L Corless, Laura McGreevey, Andrea Haley, et al.
The American Journal of Surgical Pathology|November 18, 2008
Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypesBernadette Liegl, Jason L Hornick, Christopher L Corless, et al.
The American Journal of Surgical Pathology|October 23, 2013
Leiomyoma of the gastrointestinal tract with interstitial cells of Cajal: a mimic of gastrointestinal stromal tumorAnita Deshpande, Dylan Nelson, Christopher L Corless, et al.
Expert Review of Molecular Diagnostics|March 21, 2017
Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumorsAmber E Bannon, Lillian R Klug, Christopher L Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignanciesMichael C Heinrich, Charles D Blanke, Brian J Druker, et al.
Pageof 21

Showing results (21-30 of 208) with videos related to

Sort By:
Pageof 21
American Journal of Surgery|May 15, 2010
Sentinel lymph node staging of cutaneous melanoma: predictors and outcomesMichelle C Ellis, Roshanthi Weerasinghe, Christopher L Corless, et al.
Cancer Medicine|August 29, 2014
Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathwaysMaria A Pantaleo, Margherita Nannini, Christopher L Corless, et al.
The American Journal of Dermatopathology|February 10, 2012
BRAF and KRAS mutations in sporadic glomus tumorsAndrea Chakrapani, Andrea Warrick, Dylan Nelson, et al.
Gastrointestinal Endoscopy|August 28, 2002
Embryonal rhabdomyosarcoma in a 3-year-old child diagnosed at ERCP: case report and reviewGordon C Hunt, Christopher L Corless, Annie B Terry, et al.
American Journal of Surgery|May 30, 2002
Immunosuppression impact on long-term cardiovascular complications after liver transplantationJohn M Rabkin, Christopher L Corless, Hugo R Rosen, et al.
The American Journal of Pathology|May 10, 2002
KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in sizeChristopher L Corless, Laura McGreevey, Andrea Haley, et al.
The American Journal of Surgical Pathology|November 18, 2008
Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypesBernadette Liegl, Jason L Hornick, Christopher L Corless, et al.
The American Journal of Surgical Pathology|October 23, 2013
Leiomyoma of the gastrointestinal tract with interstitial cells of Cajal: a mimic of gastrointestinal stromal tumorAnita Deshpande, Dylan Nelson, Christopher L Corless, et al.
Expert Review of Molecular Diagnostics|March 21, 2017
Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumorsAmber E Bannon, Lillian R Klug, Christopher L Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignanciesMichael C Heinrich, Charles D Blanke, Brian J Druker, et al.
Pageof 21